This study tests an experimental drug called THN391 in 15 people with early Alzheimer's disease who also have small vessel disease in the brain. Participants receive three monthly IV infusions of either THN391 or a placebo. The main goal is to check safety and how the drug behave…
Phase: PHASE1 • Sponsor: Therini Bio, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC